ARCHIVES

Hospital to Review Medenica’s Privileges, With Conditions

This article is from The Cancer Letter archive.

Vol. 19 No. 43 | November 5, 1993

Download PDF Visit The Full Archive

Related Articles

In Brief: FDA Names DeLap Directory Of Oncology

June 7, 1996

Some NCAB Members Lack Understanding f Bypass Budget’s Value, Purpose

September 1, 1989

Oral Complications Reduced By Pretherapy NIH Conference Finds

April 28, 1989

Protection Commission Asks Hew To Adopt Entire Report As Policy for Human Subject Research

April 27, 1979

NCI News: TCGA Project Selects First Three Cancers, Tissue Banks.

October 13, 2006

White House appoints NCI Director Andrew von Eschenbach acting FDA commissioner after Lester Crawford resigns.

September 30, 2005